tm logo

Monitor this mark

View On USPTO

CERENEX
Dead/Cancelled
CANCELLED - SECTION 8

section 8

on 17 Mar 2002

Last Applicant/ Owned by

Glaxo, Inc.

P.O. Box 13408

Research Triangle Park

NC

27709

Serial Number

74254364 filed on 11th Mar 1992

Registration Number

1882771 registered on 07th Mar 1995

in the Principal Register

Correspondent Address

Dickerson M. Downing

Dickerson M. Downing

345 Park Avenue

New York, NY 10154

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

CERENEX

pharmaceutical preparations and substances used for the treatment and/or alleviation of central nervous system disorders including headache, migraine and anti-emetic preparations

Classification Information

Class [005]
Pharmaceutical Products

pharmaceutical preparations and substances used for the treatment and/or alleviation of central nervous system disorders including headache, migraine and anti-emetic preparations

First Use Date in General

17th Mar 1993

First Use Date in Commerce

17th Mar 1993

Mark Details

Serial Number

No 74254364

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 354-4395

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
19th May 2009REVIEW OF CORRESPONDENCE COMPLETE
06th May 2009PAPER RECEIVED
01st Oct 2008ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
24th Sep 2008ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
27th Aug 2008AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
20th Aug 2008AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
17th Mar 2002CANCELLED SEC. 8 (6-YR)
07th Mar 1995REGISTERED-PRINCIPAL REGISTER
31st Oct 1994ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
03rd Oct 1994CORRESPONDENCE RECEIVED IN LAW OFFICE